Peter Wipf

798 total citations
30 papers, 618 citations indexed

About

Peter Wipf is a scholar working on Organic Chemistry, Molecular Biology and Neurology. According to data from OpenAlex, Peter Wipf has authored 30 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 12 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Peter Wipf's work include Chemical Synthesis and Analysis (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Synthesis and biological activity (3 papers). Peter Wipf is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Synthesis and biological activity (3 papers). Peter Wipf collaborates with scholars based in United States, Uruguay and France. Peter Wipf's co-authors include Yun-Tae Kim, David Goldstein, J S Lazo, Sungtaek Lim, John S. Lazo, Kenji Tamura, Robert Rice, Philip Coish, Hidenori Takahashi and Sonia Rodrı́guez and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Neuroscience and Accounts of Chemical Research.

In The Last Decade

Peter Wipf

30 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Wipf United States 16 381 227 50 47 39 30 618
Michaël Prakesch Canada 15 324 0.9× 287 1.3× 48 1.0× 56 1.2× 39 1.0× 25 609
Jan Sejbal Czechia 12 290 0.8× 363 1.6× 61 1.2× 86 1.8× 11 0.3× 39 653
Concepción Pérez‐Melero Spain 14 446 1.2× 257 1.1× 60 1.2× 24 0.5× 30 0.8× 25 652
Albert W. Garofalo United States 14 362 1.0× 382 1.7× 70 1.4× 32 0.7× 43 1.1× 23 725
Dennis M. O’Shea United Kingdom 10 483 1.3× 102 0.4× 23 0.5× 27 0.6× 11 0.3× 15 650
Rabindranath Tripathy United States 14 425 1.1× 212 0.9× 26 0.5× 19 0.4× 9 0.2× 18 610
Christopher M. Tegley United States 17 290 0.8× 255 1.1× 84 1.7× 28 0.6× 10 0.3× 22 667
Douglas A. Pippin United States 9 486 1.3× 361 1.6× 91 1.8× 29 0.6× 8 0.2× 15 792
Dominique Lesuisse France 16 336 0.9× 370 1.6× 46 0.9× 34 0.7× 5 0.1× 38 745
Alexey Rivkin United States 18 592 1.6× 286 1.3× 185 3.7× 57 1.2× 8 0.2× 28 863

Countries citing papers authored by Peter Wipf

Since Specialization
Citations

This map shows the geographic impact of Peter Wipf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wipf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wipf more than expected).

Fields of papers citing papers by Peter Wipf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wipf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wipf. The network helps show where Peter Wipf may publish in the future.

Co-authorship network of co-authors of Peter Wipf

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Wipf. A scholar is included among the top collaborators of Peter Wipf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Wipf. Peter Wipf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberger, Joel S., Wen‐Chi Hou, Donna Shields, et al.. (2024). SARS-CoV-2 Spike Protein Induces Oxidative Stress and Senescence in Mouse and Human Lung. In Vivo. 38(4). 1546–1556. 3 indexed citations
2.
Tarr, Tyler B., Waqas Malick, David Lacomis, et al.. (2013). Evaluation of a Novel Calcium Channel Agonist for Therapeutic Potential in Lambert-Eaton Myasthenic Syndrome. Journal of Neuroscience. 33(25). 10559–10567. 37 indexed citations
3.
Hoye, Adam T., Jennifer E. Davoren, Peter Wipf, Mitchell P. Fink, & Valerian E. Kagan. (2012). Correction to Targeting Mitochondria. Accounts of Chemical Research. 45(12). 2222–2222. 20 indexed citations
4.
Sasmal, Aniruddha, Tsuyoshi Taniguchi, Peter Wipf, & Dennis P. Curran. (2012). Memory of chirality in rebound cyclizations of α-amide radicals. Canadian Journal of Chemistry. 91(1). 1–5. 15 indexed citations
5.
Wipf, Peter, Shuzhi Dong, Paul A. Johnston, et al.. (2009). A Case Study from the Chemistry Core of the Pittsburgh Molecular Library Screening Center: The Polo-like Kinase Polo-Box Domain (Plk1- PBD). Current Topics in Medicinal Chemistry. 9(13). 1194–1205. 9 indexed citations
6.
Burnett, James C., Jonathan E. Nuss, Tam Luong Nguyen, et al.. (2009). Pharmacophore-guided lead optimization: The rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease. Bioorganic & Medicinal Chemistry Letters. 19(19). 5811–5813. 37 indexed citations
7.
Fajardo, José, Jenny Saldaña, Laura Domínguez, et al.. (2009). Synthesis and Evaluation of Anthelmintic and Cytotoxic Properties of [2,5]Bis-1,3-Azole Analogs of Bengazoles. Letters in Drug Design & Discovery. 6(6). 413–419. 7 indexed citations
8.
Zuber, Gérard, Peter Wipf, & David N. Beratan. (2008). Exploring the Optical Activity Tensor by Anisotropic Rayleigh Optical Activity Scattering. ChemPhysChem. 9(4). 504–504. 1 indexed citations
9.
Wipf, Peter, Haibiao Gong, Jelena M. Janjic, et al.. (2007). New Opportunities for Pregnane X Receptor (PXR) Targeting in Drug Development. Lessons from Enantio- and Species-Specific PXR Ligands Identified from A Discovery Library of Amino Acid Analogues. Mini-Reviews in Medicinal Chemistry. 7(6). 617–625. 5 indexed citations
10.
Cossy, Janine, Damien Belotti, Marni Brisson, et al.. (2006). Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors. Bioorganic & Medicinal Chemistry. 14(18). 6283–6287. 20 indexed citations
11.
Wipf, Peter. (2005). Reagents for high-throughput solid-phase and solution-phase organic synthesis. John Wiley & Sons eBooks. 4 indexed citations
12.
Powis, Garth, et al.. (2004). Pharmacokinetic and pharmacodynamic studies of a novel antitumor wortmannin analogue inhibitor of phosphatidylinositol-3-kinase. 64. 1098–1098. 1 indexed citations
13.
Wipf, Peter. (2002). Modern Organocopper Chemistry. Synthesis. 2317–2317. 49 indexed citations
14.
Ducruet, Alexander P., Robert Rice, Kenji Tamura, et al.. (2000). Identification of new Cdc25 dual specificity phosphatase inhibitors in a targeted small molecule array. Bioorganic & Medicinal Chemistry. 8(6). 1451–1466. 28 indexed citations
15.
Lazo, J S & Peter Wipf. (2000). Combinatorial Chemistry and Contemporary Pharmacology. Journal of Pharmacology and Experimental Therapeutics. 293(3). 705–709. 14 indexed citations
16.
Lazo, J S & Peter Wipf. (2000). ChemInform Abstract: Combinatorial Chemistry and Contemporary Pharmacology. ChemInform. 31(43). 705–9. 23 indexed citations
17.
Tamura, Kenji, Robert Rice, Peter Wipf, & John S. Lazo. (1999). Dual G1 and G2/M phase inhibition by SC-ααδ9, a combinatorially derived Cdc25 phosphatase inhibitor. Oncogene. 18(50). 6989–6996. 20 indexed citations
18.
Wipf, Peter, Yun-Tae Kim, & David Goldstein. (1995). Asymmetric Total Synthesis of the Stemona Alkaloid (-)-Stenine. Journal of the American Chemical Society. 117(45). 11106–11112. 119 indexed citations
19.
Wipf, Peter & Yun-Tae Kim. (1994). Synthesis of the Antitumor Antibiotic LL-C10037.alpha.. The Journal of Organic Chemistry. 59(13). 3518–3519. 25 indexed citations
20.
Ireland, Robert E., et al.. (1990). Methodology for the enantioselective synthesis of aldols and other 1,3-dioxygenated systems. The Journal of Organic Chemistry. 55(5). 1423–1424. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaël Prakesch Breakdown of academic impact, for papers by Jan Sejbal Breakdown of academic impact, for papers by Concepción Pérez‐Melero Breakdown of academic impact, for papers by Albert W. Garofalo Breakdown of academic impact, for papers by Dennis M. O’Shea Breakdown of academic impact, for papers by Rabindranath Tripathy Breakdown of academic impact, for papers by Christopher M. Tegley Breakdown of academic impact, for papers by Douglas A. Pippin Breakdown of academic impact, for papers by Dominique Lesuisse Breakdown of academic impact, for papers by Alexey Rivkin
Rankless by CCL
2026